What is Pacific Health's earnings per share (EPS)?

Pacific Health (PFHO) reported diluted earnings per share of $0.11 for fiscal year 2025. This represents a 57.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Pacific Health Financials

PFHO

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Pacific Health (PFHO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PFHO FY2025 2026-04-30

Pacific Health Care’s earnings engine is unusually cash-efficient, and its growth appears internally financed rather than balance-sheet driven.

Across FY2023-FY2025, cumulative operating cash flow of $2.8M closely tracked cumulative net income of $3.0M. Free cash flow still totaled $2.7M because capital spending over the same span was only $49K, so reported earnings were not being consumed by heavy reinvestment or working-capital buildup.

From FY2023 to FY2025, operating margin widened from 12.1% to 14.9% even as SG&A rose, which suggests added revenue was landing in profit faster than overhead was growing. Because gross margin is not reported here, the cleanest read is operating leverage through cost control rather than a claim about pricing or mix.

FY2025 ended with only $389K of total liabilities against $13.5M of assets, giving the company a distinctly conservative balance-sheet posture. Equity has kept building through retained earnings over recent years, so the business looks increasingly self-funded instead of relying on creditors to support its expansion.

Financial Health Signals

Financial Profile 66/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Pacific Health's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Pacific Health has an operating margin of 14.9%, meaning the company retains $15 of operating profit per $100 of revenue. This results in a moderate score of 54/100, indicating healthy but not exceptional operating efficiency. This is up from 14.1% the prior year.

Growth

Pacific Health's revenue grew 10.7% year-over-year to $6.7M, a solid pace of expansion. This earns a growth score of 49/100.

Leverage

100

Pacific Health carries a low D/E ratio of 0.03, meaning only $0.03 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 34.45, Pacific Health holds $34.45 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

Pacific Health has a free cash flow margin of 16.9%, earning a moderate score of 63/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Pacific Health's ROE of 10.6% shows moderate profitability relative to equity, earning a score of 31/100. This is up from 7.6% the prior year.

Altman Z-Score Safe

24.96

Pacific Health scores 24.96, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($14.1M) relative to total liabilities ($389K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

6/9

Pacific Health passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.84x

For every $1 of reported earnings, Pacific Health generates $0.84 in operating cash flow ($1.2M OCF vs $1.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe

657.7x

Pacific Health earns $657.7 in operating income for every $1 of interest expense ($1.0M vs $2K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.7M

YoY+10.7%

5Y CAGR+2.1%

10Y CAGR-2.0%

Pacific Health generated $6.7M in revenue in fiscal year 2025. This represents an increase of 10.7% from the prior year.

EBITDA

$1.0M

YoY+15.6%

5Y CAGR+3.2%

10Y CAGR-9.9%

Pacific Health's EBITDA was $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 15.6% from the prior year.

Net Income

$1.4M

YoY+57.0%

5Y CAGR+20.4%

10Y CAGR-1.9%

Pacific Health reported $1.4M in net income in fiscal year 2025. This represents an increase of 57.0% from the prior year.

EPS (Diluted)

$0.11

YoY+57.1%

5Y CAGR+22.4%

Pacific Health earned $0.11 per diluted share (EPS) in fiscal year 2025. This represents an increase of 57.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$1.1M

YoY+70.8%

5Y CAGR+4.0%

10Y CAGR-5.5%

Pacific Health generated $1.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 70.8% from the prior year.

Cash & Debt

$2.2M

YoY+4.7%

5Y CAGR-25.6%

10Y CAGR-5.5%

Pacific Health held $2.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

13M

YoY+0.0%

5Y CAGR+0.0%

Pacific Health had 13M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

14.9%

YoY+0.9pp

5Y CAGR+1.3pp

10Y CAGR-19.4pp

Pacific Health's operating margin was 14.9% in fiscal year 2025, reflecting core business profitability. This is up 0.9 percentage points from the prior year.

Net Margin

20.7%

YoY+6.1pp

5Y CAGR+11.6pp

10Y CAGR+0.3pp

Pacific Health's net profit margin was 20.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 6.1 percentage points from the prior year.

Return on Equity

10.6%

YoY+3.0pp

5Y CAGR+5.0pp

10Y CAGR-22.1pp

Pacific Health's ROE was 10.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.0 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$23K

YoY+154.9%

5Y CAGR-15.4%

10Y CAGR-17.4%

Pacific Health invested $23K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 154.9% from the prior year.

PFHO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6.7M+10.7%	$6.1M+7.7%	$5.6M-2.0%	$5.7M+6.3%	$5.4M-10.6%	$6.0M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$767K+5.6%	$726K+17.7%	$617K-12.6%	$706K+7.2%	$658K-5.4%	$696K
Operating Income	$1.0M+17.4%	$853K+25.7%	$679K+1.9%	$666K+29.0%	$516K-37.0%	$820K
Interest Expense	$2K-57.2%	$4K	$0	$0+100.0%	-$5K	$0
Income Tax	$507K+33.4%	$380K+18.6%	$321K+59.9%	$200K-0.3%	$201K-25.7%	$271K
Net Income	$1.4M+57.0%	$884K+15.1%	$768K+55.8%	$493K-50.5%	$995K+81.1%	$550K
EPS (Diluted)	$0.11+57.1%	$0.07+16.7%	$0.06+50.0%	$0.04-50.0%	$0.08+100.0%	$0.04

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$1.5M-5.4%	$1.6M-0.3%	$1.6M-8.1%	$1.7M-5.1%	$1.8M+11.9%	$1.6M+8.3%	$1.5M-2.6%	$1.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$181K+9.2%	$166K-11.1%	$186K-18.3%	$228K+21.5%	$188K-4.5%	$196K+7.5%	$183K-9.6%	$202K
Operating Income	$173K-3.0%	$178K-13.2%	$205K-32.5%	$304K-3.5%	$314K-5.8%	$334K+120.3%	$152K-21.1%	$192K
Interest Expense	$0	$0	$0	$0-100.0%	$2K-57.2%	$4K	$0	$0
Income Tax	$74K+56.9%	$47K-45.7%	$87K-66.3%	$259K+127.0%	$114K-11.8%	$129K+43.1%	$90K+8.3%	$83K
Net Income	$194K-17.6%	$235K+5.4%	$223K-65.0%	$637K+117.6%	$293K-1.0%	$296K+69.1%	$175K-18.9%	$216K
EPS (Diluted)	$0.02	N/A	$0.02-60.0%	$0.05+150.0%	$0.02	N/A	$0.01-50.0%	$0.02

PFHO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$13.5M+8.3%	$12.4M+5.8%	$11.8M-2.5%	$12.1M+6.3%	$11.3M+2.0%	$11.1M
Current Assets	$13.4M+8.5%	$12.3M+6.6%	$11.6M-2.7%	$11.9M+6.8%	$11.1M+4.6%	$10.6M
Cash & Equivalents	$2.2M+4.7%	$2.1M-17.0%	$2.5M+22.5%	$2.0M-79.8%	$10.1M+6.2%	$9.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.0M-2.3%	$1.0M+0.8%	$1.0M+8.3%	$943K+1.6%	$928K-12.7%	$1.1M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$389K-47.9%	$746K-21.4%	$948K+29.0%	$735K+44.6%	$508K-60.2%	$1.3M
Current Liabilities	$389K-47.9%	$746K-20.4%	$936K+32.1%	$709K+41.4%	$501K-51.9%	$1.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$13.1M+11.9%	$11.7M+8.2%	$10.8M-4.5%	$11.3M+4.6%	$10.8M+10.1%	$9.8M
Retained Earnings	$12.6M+12.3%	$11.3M+8.5%	$10.4M-4.7%	$10.9M+4.7%	$10.4M+10.6%	$9.4M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$13.8M+2.2%	$13.5M+1.3%	$13.3M-0.2%	$13.3M+5.2%	$12.7M+1.8%	$12.4M+2.4%	$12.1M+1.6%	$11.9M
Current Assets	$13.7M+2.3%	$13.4M+1.2%	$13.2M0.0%	$13.2M+5.3%	$12.6M+1.8%	$12.3M+2.2%	$12.1M+1.7%	$11.9M
Cash & Equivalents	$2.4M+10.5%	$2.2M-0.5%	$2.2M+1.1%	$2.2M-8.5%	$2.4M+13.9%	$2.1M-18.7%	$2.5M-2.8%	$2.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.1M+6.0%	$1.0M-1.2%	$1.0M-6.8%	$1.1M+17.0%	$933K-9.3%	$1.0M-5.9%	$1.1M+16.2%	$941K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$497K+27.8%	$389K-14.3%	$453K-35.1%	$698K+3.1%	$677K-9.2%	$746K-0.3%	$748K+3.0%	$726K
Current Liabilities	$497K+27.8%	$389K-14.3%	$453K-35.1%	$698K+3.1%	$677K-9.2%	$746K-0.3%	$748K+3.0%	$726K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$13.3M+1.5%	$13.1M+1.8%	$12.8M+1.8%	$12.6M+5.3%	$12.0M+2.5%	$11.7M+2.6%	$11.4M+1.6%	$11.2M
Retained Earnings	$12.8M+1.5%	$12.6M+1.9%	$12.4M+1.8%	$12.2M+5.5%	$11.6M+2.6%	$11.3M+2.7%	$11.0M+1.6%	$10.8M

PFHO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$1.2M+71.9%	$675K-27.6%	$932K+31.1%	$711K+84.1%	$386K-60.9%	$987K
Capital Expenditures	$23K+154.9%	$9K-47.9%	$18K-54.9%	$39K+111.5%	$18K-65.9%	$54K
Free Cash Flow	$1.1M+70.8%	$666K-27.2%	$915K+36.1%	$672K+82.7%	$368K-60.6%	$934K
Investing Cash Flow	-$990K+12.7%	-$1.1M-240.5%	$807K+109.2%	-$8.8M-47571.8%	-$18K+65.9%	-$54K
Financing Cash Flow	-$72K-304.8%	$35K+102.8%	-$1.3M	$0-100.0%	$219K-52.5%	$461K
Dividends Paid	$37K	$0-100.0%	$1.3M	$0	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$228K-35.0%	$351K+1370.7%	$24K-94.8%	$455K+37.6%	$331K-41.8%	$568K+1654.5%	-$37K+75.2%	-$147K
Capital Expenditures	$0-100.0%	$14K+1428.3%	$907	$0-100.0%	$9K+409.3%	$2K-0.6%	$2K-17.2%	$2K
Free Cash Flow	$228K-32.4%	$337K+1368.4%	$23K-95.0%	$455K+41.2%	$322K-43.1%	$566K+1581.7%	-$38K+74.4%	-$149K
Investing Cash Flow	$0+100.0%	-$325K-35699.8%	-$907+99.9%	-$656K-7608.9%	-$9K+99.1%	-$950K-56428.7%	-$2K+99.1%	-$178K
Financing Cash Flow	$0+100.0%	-$36K-28900.0%	-$125+80.0%	-$625+98.2%	-$35K0.0%	-$35K0.0%	-$35K-133.3%	$106K
Dividends Paid	N/A	$36K+28900.0%	$125	N/A	N/A	$0	$0+100.0%	-$14K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

PFHO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	14.9%+0.9pp	14.1%+2.0pp	12.0%+0.5pp	11.6%+2.0pp	9.6%-4.0pp	13.6%
Net Margin	20.7%+6.1pp	14.6%+0.9pp	13.6%+5.1pp	8.6%-9.8pp	18.4%+9.3pp	9.1%
Return on Equity	10.6%+3.0pp	7.6%+0.5pp	7.1%+2.7pp	4.4%-4.8pp	9.2%+3.6pp	5.6%
Return on Assets	10.3%+3.2pp	7.1%+0.6pp	6.5%+2.4pp	4.1%-4.7pp	8.8%+3.8pp	5.0%
Current Ratio	34.45+17.9	16.54+4.2	12.36-4.4	16.78-5.4	22.23+12.0	10.21
Debt-to-Equity	0.03-0.0	0.06-0.0	0.09+0.0	0.07+0.0	0.05-0.1	0.13
FCF Margin	16.9%+6.0pp	11.0%-5.3pp	16.3%+4.5pp	11.7%+4.9pp	6.8%-8.6pp	15.4%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	11.5%+0.3pp	11.3%-1.7pp	12.9%-4.7pp	17.6%+0.3pp	17.3%-3.3pp	20.5%+10.4pp	10.1%-2.4pp	12.5%
Net Margin	12.9%-1.9pp	14.8%+0.8pp	14.1%-22.8pp	36.9%+20.8pp	16.1%-2.1pp	18.2%+6.5pp	11.7%-2.3pp	14.0%
Return on Equity	1.5%-0.3pp	1.8%+0.1pp	1.7%-3.3pp	5.1%+2.6pp	2.4%-0.1pp	2.5%+1.0pp	1.5%-0.4pp	1.9%
Return on Assets	1.4%-0.3pp	1.8%+0.1pp	1.7%-3.1pp	4.8%+2.5pp	2.3%-0.1pp	2.4%+0.9pp	1.4%-0.4pp	1.8%
Current Ratio	27.58-6.9	34.45+5.3	29.17+10.2	18.93+0.4	18.55+2.0	16.54+0.4	16.15-0.2	16.35
Debt-to-Equity	0.040.0	0.030.0	0.04-0.0	0.060.0	0.060.0	0.060.0	0.070.0	0.06
FCF Margin	15.2%-6.1pp	21.3%+19.8pp	1.5%-24.9pp	26.4%+8.6pp	17.7%-17.1pp	34.8%+37.4pp	-2.5%+7.1pp	-9.7%

Similar Companies

Marpai Inc MRAI

$6.7M

Hemostemix HMTXF

$8.1M

Aurora Spine ASAPF

$13.8M

Pharma-Bio Serv Inc PBSV

$12.8M

Yourway Cannabis Brands Inc YOURF

$17.8M

Frequently Asked Questions

What is Pacific Health's annual revenue?

Pacific Health (PFHO) reported $6.7M in total revenue for fiscal year 2025. This represents a 10.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Pacific Health's revenue growing?

Pacific Health (PFHO) revenue grew by 10.7% year-over-year, from $6.1M to $6.7M in fiscal year 2025.

Is Pacific Health profitable?

Yes, Pacific Health (PFHO) reported a net income of $1.4M in fiscal year 2025, with a net profit margin of 20.7%.

What is Pacific Health's EBITDA?

Pacific Health (PFHO) had EBITDA of $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Pacific Health's operating margin?

Pacific Health (PFHO) had an operating margin of 14.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Pacific Health's net profit margin?

Pacific Health (PFHO) had a net profit margin of 20.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Pacific Health's return on equity (ROE)?

Pacific Health (PFHO) has a return on equity of 10.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Pacific Health's free cash flow?

Pacific Health (PFHO) generated $1.1M in free cash flow during fiscal year 2025. This represents a 70.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Pacific Health's operating cash flow?

Pacific Health (PFHO) generated $1.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Pacific Health's total assets?

Pacific Health (PFHO) had $13.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Pacific Health's capital expenditures?

Pacific Health (PFHO) invested $23K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Pacific Health have outstanding?

Pacific Health (PFHO) had 13M shares outstanding as of fiscal year 2025.

What is Pacific Health's current ratio?

Pacific Health (PFHO) had a current ratio of 34.45 as of fiscal year 2025, which is generally considered healthy.

What is Pacific Health's debt-to-equity ratio?

Pacific Health (PFHO) had a debt-to-equity ratio of 0.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Pacific Health's return on assets (ROA)?

Pacific Health (PFHO) had a return on assets of 10.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Pacific Health's Altman Z-Score?

Pacific Health (PFHO) has an Altman Z-Score of 24.96, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Pacific Health's Piotroski F-Score?

Pacific Health (PFHO) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Pacific Health's earnings high quality?

Pacific Health (PFHO) has an earnings quality ratio of 0.84x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Pacific Health cover its interest payments?

Pacific Health (PFHO) has an interest coverage ratio of 657.7x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Pacific Health?

Pacific Health (PFHO) scores 66 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.